Low Pressure Pneumoperitoneum for Postoperative Shoulder Pain
Trial Summary
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Low pressure pneumoperitoneum with AirSeal device for reducing postoperative shoulder pain?
Some studies suggest that using the AirSeal device for low-pressure pneumoperitoneum during laparoscopic surgery may reduce postoperative pain, as two out of three studies showed a significant decrease in pain. However, results are inconsistent, and more research is needed to confirm these findings.12345
Is low pressure pneumoperitoneum with the AirSeal device safe for humans?
How does the low pressure pneumoperitoneum with AirSeal device treatment differ from other treatments for postoperative shoulder pain?
The low pressure pneumoperitoneum with AirSeal device is unique because it uses a special system to maintain low pressure during laparoscopic surgery, which can reduce postoperative shoulder pain by minimizing the amount of gas left in the body. This approach is different from standard methods that use higher pressure, potentially leading to more discomfort after surgery.12467
What is the purpose of this trial?
The goal of this clinical trial is to evaluate the incidence and severity of post-operative shoulder pain following elective robot-assisted hiatal hernia repair in hopes of reducing pain and associated costs as well as clinic and emergency department visits due to this pain. You will undergo standard robot-assisted hiatal hernia repair with the standard postoperative care. The only difference is that you may be selected for the group where lower pressures used to fill your abdomen with carbon dioxide will be used, and you will be asked to fill out logs regarding your pain postoperatively. You will have postoperative appointments that are standard following this procedure.
Eligibility Criteria
This trial is for individuals undergoing elective robot-assisted hiatal hernia repair. Participants must be suitable for the surgery and willing to log their postoperative pain. Specific inclusion or exclusion criteria are not provided, but typically these would relate to overall health status and any conditions that might interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo standard robot-assisted hiatal hernia repair with either low or standard pressure pneumoperitoneum
Postoperative Monitoring
Participants' postoperative shoulder pain is monitored, including severity assessments on POD #0, POD #1, and at 1 and 2 weeks post-op
Follow-up
Participants are monitored for safety and effectiveness after treatment, including readmission rates and quality of life assessments
Treatment Details
Interventions
- Low pressure pneumoperitoneum with AirSeal device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Riverside University Health System Medical Center
Lead Sponsor